Ryan Specialty (NYSE:RYAN – Get Free Report) will likely be posting its Q4 2025 results after the market closes on Thursday, February 12th. Analysts expect Ryan Specialty to post earnings of $0.50 per share and revenue of $777.4260 million for the quarter. Interested persons may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, February 12, 2026 at 5:00 PM ET.
Ryan Specialty Trading Up 1.4%
NYSE:RYAN opened at $47.62 on Thursday. The company has a current ratio of 1.00, a quick ratio of 1.00 and a debt-to-equity ratio of 2.72. Ryan Specialty has a 1-year low of $46.18 and a 1-year high of $77.16. The firm has a market capitalization of $12.56 billion, a price-to-earnings ratio of 103.52, a PEG ratio of 1.19 and a beta of 0.62. The business’s 50-day moving average price is $51.96 and its two-hundred day moving average price is $54.97.
Insiders Place Their Bets
In other Ryan Specialty news, CEO Timothy William Turner sold 129,570 shares of the stock in a transaction dated Friday, December 12th. The stock was sold at an average price of $53.61, for a total transaction of $6,946,247.70. Following the completion of the transaction, the chief executive officer owned 12,553 shares in the company, valued at approximately $672,966.33. This represents a 91.17% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 52.21% of the company’s stock.
Institutional Investors Weigh In On Ryan Specialty
Analysts Set New Price Targets
Several research firms recently weighed in on RYAN. Morgan Stanley set a $61.00 price objective on shares of Ryan Specialty in a research note on Tuesday, December 16th. The Goldman Sachs Group set a $61.00 price target on shares of Ryan Specialty in a research report on Wednesday, January 7th. Barclays lowered their price objective on shares of Ryan Specialty from $65.00 to $58.00 and set an “overweight” rating for the company in a research report on Thursday, January 8th. Mizuho set a $60.00 price objective on Ryan Specialty in a research note on Wednesday, January 14th. Finally, Piper Sandler started coverage on Ryan Specialty in a research note on Thursday, November 20th. They issued a “neutral” rating and a $60.00 target price for the company. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $64.19.
Check Out Our Latest Report on Ryan Specialty
Ryan Specialty Company Profile
Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.
Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.
Featured Stories
- Five stocks we like better than Ryan Specialty
- The day the gold market broke
- Buy this Gold Stock Before May 2026
- Forget AI, This Will Be the Next Big Tech Breakthrough
- Trump Planning to Use Public Law 63-43: Prepare Now
- New gold price target
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.
